Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

DexCom, Inc. - Common Stock (NQ: DXCM )

68.48 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2
...
27 28 29 30 31 32 33 34 Next >
22 Stocks Moving in Friday's Pre-Market Session
Gainers Image Sensing Systems, Inc. (NASDAQ: ISNS) rose 30.7% to $6.00 in pre-market trading after the company announced it initiated a quarterly dividend of $0.12 per share,... 
Via Benzinga
Dexcom Inc (DXCM) Q1 2021 Earnings Call Transcript
DXCM earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
15 Stocks Moving In Thursday's After-Hours Session
Gainers Amazon (NASDAQ: AMZN) shares are trading higher after the company reported better-than-expected Q1 EPS and sales results. The company also issued Q2 sales guidance above... 
Via Benzinga
Recap: DexCom Q1 Earnings
Shares of DexCom (NASDAQ:DXCM) fell in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were down 25.00% over the past year to... 
Via Benzinga
Dexcom Beats First-Quarter Expectations, But Shares Tumble
Dexcom stock tumbled late Thursday after the diabetes devices company reported adjusted earnings of 33 cents per share on $505 million in sales. 
Via Investor's Business Daily
Dexcom Reports First Quarter 2021 Financial Results
From DexCom, Inc.
Via Business Wire
3 Unstoppable Growth Stocks You Can Hold for Decades
Each proved its worth during the coronavirus pandemic. 
Via The Motley Fool
Exposures COVID-19
Senseonics Stock Will Likely Rise on the Same Trajectory As DexCom
Senseonics will rise on the same trajectory as DexCom. SENS stock could rise 5 to 10 times over the next 5 years with FDA approval. 
Via InvestorPlace
Exposures Product Safety
The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:... 
Via Benzinga
The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx
Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:... 
Via Benzinga
Exposures Product Safety
Benzinga's Top Ratings Upgrades, Downgrades For April 15, 2021
Upgrades According to JP Morgan, the prior rating for Vipshop Holdings Ltd (NYSE:VIPS) was changed from Neutral to Overweight. In the fourth quarter, Vipshop Holdings... 
Via Benzinga
< Previous 1 2
...
27 28 29 30 31 32 33 34 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.